**Core Concept**
The question is testing the knowledge of safe muscle relaxants in patients with renal failure. Renal failure affects the excretion of drugs, making it crucial to choose a muscle relaxant that is not primarily eliminated by the kidneys.

**Why the Correct Answer is Right**
The correct answer is Rocuronium because it is primarily metabolized by the liver and excreted in the bile, making it a safe choice in patients with renal failure. Rocuronium has a short duration of action and does not accumulate in patients with impaired renal function. Its elimination half-life is not significantly affected by renal impairment, making it a reliable option for muscle relaxation in this patient population.

**Why Each Wrong Option is Incorrect**
**Option A:** Vecuronium - While vecuronium is a safe choice in some cases of renal failure, it is not the best option because it can accumulate in patients with severe renal impairment, leading to prolonged neuromuscular blockade.

**Option B:** Pancuronium - Pancuronium is not a safe choice in renal failure because it is primarily eliminated by the kidneys and can accumulate in patients with impaired renal function, leading to prolonged neuromuscular blockade and other adverse effects.

**Option C:** Atracurium - Atracurium is a safe choice in renal failure because it undergoes Hoffman elimination, a spontaneous non-enzymatic degradation process that is not affected by renal function. However, it is not the best option because it can cause histamine release and other adverse effects.

**Clinical Pearl / High-Yield Fact**
When choosing a muscle relaxant in patients with renal failure, consider the elimination pathway of the drug. Drugs primarily eliminated by the kidneys may accumulate and cause prolonged neuromuscular blockade, while drugs primarily metabolized by the liver and excreted in the bile are safer choices.

**Correct Answer: C. Atracurium**